American Funds American Mutual 529F (CMLFX)
49.54
+0.45 (+0.92%)
USD |
Apr 21
Returns Chart
Key Stats
Customize
Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
---|---|---|---|
0.65% | 78.05B | 1.89% | 24.00% |
1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
3.165B | 36.78% | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
The investment seeks current income, growth of capital and conservation of principal. The fund invests primarily in common stocks of companies that are likely to participate in the growth of the American economy and whose dividends appear to be sustainable. It invests primarily in securities of issuers domiciled in the United States and Canada. The fund may also invest in bonds and other debt securities, including those issued by the U.S. government and by federal agencies and instrumentalities. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | AMRMX |
Equity Style | Large Cap/Value |
Fixed Income Style | -- |
Broad Asset Class | US Equity |
Broad Category | Equity |
Category Name | Large Value |
Category Index | Russell 1000 Value TR USD |
Prospectus Objective | Growth and Income |
Fund Owner Firm Name | American Funds |
Prospectus Benchmark Index | |
S&P 500 TR USD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Manager Tenure | |
James Lovelace | 15.26 yrs |
James Terrile | 15.26 yrs |
Joyce Gordon | 15.26 yrs |
Dylan Yolles | 14.26 yrs |
William Robbins | 13.26 yrs |
Cheryl Frank | 7.25 yrs |
Bradley Vogt | 6.25 yrs |
Charles Ellwein | 4.25 yrs |
Grant Cambridge | 0.25 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
3
3.165B
-6.940B
Category Low
8.818B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of March 31, 2021
Performance Versus Category
As of April 21, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of April 21, 2021.
Asset Allocation
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Microsoft Corp | 3.96% | 260.81 | 0.09% |
Comcast Corp Class A | 3.22% | 54.71 | 0.10% |
Gilead Sciences Inc | 2.67% | 66.18 | -0.91% |
Amgen Inc | 2.32% | 256.25 | -0.98% |
Linde PLC | 2.23% | 291.14 | -0.28% |
JPMorgan Chase & Co | 2.21% | 149.34 | -0.80% |
The Home Depot Inc | 2.15% | 323.44 | -0.77% |
Abbott Laboratories | 2.09% | 124.65 | 1.67% |
UnitedHealth Group Inc | 1.89% | 398.10 | -0.18% |
Raytheon Technologies Corp | 1.60% | 79.86 | 1.26% |
Basic Info
Investment Strategy | |
The investment seeks current income, growth of capital and conservation of principal. The fund invests primarily in common stocks of companies that are likely to participate in the growth of the American economy and whose dividends appear to be sustainable. It invests primarily in securities of issuers domiciled in the United States and Canada. The fund may also invest in bonds and other debt securities, including those issued by the U.S. government and by federal agencies and instrumentalities. |
General | |
Security Type | Mutual Fund |
Oldest Share Symbol | AMRMX |
Equity Style | Large Cap/Value |
Fixed Income Style | -- |
Broad Asset Class | US Equity |
Broad Category | Equity |
Category Name | Large Value |
Category Index | Russell 1000 Value TR USD |
Prospectus Objective | Growth and Income |
Fund Owner Firm Name | American Funds |
Prospectus Benchmark Index | |
S&P 500 TR USD | 100.0% |
Broad Asset Class Benchmark Index | |
^SPXTR | 100.0% |
Manager Tenure | |
James Lovelace | 15.26 yrs |
James Terrile | 15.26 yrs |
Joyce Gordon | 15.26 yrs |
Dylan Yolles | 14.26 yrs |
William Robbins | 13.26 yrs |
Cheryl Frank | 7.25 yrs |
Bradley Vogt | 6.25 yrs |
Charles Ellwein | 4.25 yrs |
Grant Cambridge | 0.25 yrs |
Fundamentals
General | |
Distribution Yield | Upgrade |
Dividend Yield TTM (4-21-21) | 1.89% |
30-Day SEC Yield (3-31-21) | Upgrade |
7-Day SEC Yield (8-31-17) | Upgrade |
Number of Holdings | Upgrade |
Stock | |
Weighted Average PE Ratio | 24.72 |
Weighted Average Price to Sales Ratio | Upgrade |
Weighted Average Price to Book Ratio | Upgrade |
Weighted Median ROE | Upgrade |
Weighted Median ROA | Upgrade |
Forecasted Dividend Yield | Upgrade |
Forecasted PE Ratio | Upgrade |
Forecasted Price to Sales Ratio | Upgrade |
Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2021
Growth Estimates
Fund Details
Key Dates | |
Inception Date | 9/17/2002 |
Last Annual Report Date | 10/31/2020 |
Last Prospectus Date | 1/1/2021 |
Share Classes | |
AFMFX | Inst |
AMFCX | C |
AMFFX | Other |
AMRFX | Other |
AMRMX | A |
CMLAX | A |
CMLCX | C |
CMLEX | Other |
FFFMX | Other |
FFMMX | Other |
RMEBX | Retirement |
RMFAX | Retirement |
RMFBX | Retirement |
RMFCX | Retirement |
RMFEX | Retirement |
RMFFX | Retirement |
RMFGX | Retirement |
RMFHX | Retirement |
Attributes | |
Enhanced Index Fund | No |
Index Fund | No |
Inverse Fund | No |
Leveraged Fund | No |
Fund of Funds | No |
Currency Hedged Fund | No |
Synthetic Replication Fund | No |
Has Dividend Investment Plan | No |
Socially Responsible Fund | No |